HC Wainwright & Co. Maintains Buy on Icecure Medical, Lowers Price Target to $2.5
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained a Buy rating on Icecure Medical but lowered the price target from $3 to $2.5.
August 21, 2024 | 11:53 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HC Wainwright & Co. has maintained a Buy rating on Icecure Medical but lowered the price target from $3 to $2.5.
The maintenance of a Buy rating suggests continued confidence in the stock, but the lowered price target indicates a more cautious outlook on its short-term potential. This mixed signal could lead to a slight negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100